Corrigendum to ‘Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities’: [Clinical Lung Cancer 21(2020) e164-e168] (Clinical Lung Cancer (2020) 21(e164-e168) (S1525730419302864), (10.1016/j.cllc.2019.10.012))

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that we failed to acknowledge collaborators without whom this project would have been impossible: Ashley Benner, MPH; Michelle DeMist, PMP; Hongfang Liu PhD; Anne M. Murray, MD, MSc (Hennepin HealthCare, Minneapolis, MN); Douglas J Rausch, MD MSc (Hennepin HealthCare, Minneapolis, MN); Gretchen Sieger; Liwei Wang, MD, PhD; Stephen C Waring, DVM, PhD, FACE This research was supported by the National Institutes of Health's National Center for Advancing Translational Sciences, grant UL1TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health's National Center for Advancing Translational Sciences. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)e793
JournalClinical Lung Cancer
Volume22
Issue number5
DOIs
StatePublished - Sep 2021
Externally publishedYes

Bibliographical note

Funding Information:
This research was supported by the National Institutes of Health’s National Center for Advancing Translational Sciences, grant UL1TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health’s National Center for Advancing Translational Sciences.

Publisher Copyright:
© 2020 Elsevier Inc.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities’: [Clinical Lung Cancer 21(2020) e164-e168] (Clinical Lung Cancer (2020) 21(e164-e168) (S1525730419302864), (10.1016/j.cllc.2019.10.012))'. Together they form a unique fingerprint.

Cite this